
Sign up to save your podcasts
Or


Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
By The Lancet NeurologyJeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.

43,589 Listeners

299 Listeners

506 Listeners

52 Listeners

113,475 Listeners

90 Listeners

521 Listeners

190 Listeners

58 Listeners

81 Listeners

0 Listeners